[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.37 número5
Has 10000 "Rev. Bras. Hematol. Hemoter. vol.37 número5" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.37 número5".
Rev. Bras. Hematol. Hemoter. vol.37 número5
... Monoclonal B-cell lymphocytosis in individuals from sporadic (non-familial) chronic lymphocytic leukemia families persists over time, but does not progress to chronic B-cell lymphoprolif[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.37 número5
... Conclusion: Left ventricular hypertrophy was observed in more than one-third of the young patients with sickle cell anemia with this finding being inversely correlated to the hemoglobin [r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.37 número5
... This study evaluated the risk factors for low hematocrit and iron depletion among prospective blood donors in a large Brazilian blood center.. Method: A case–control study of 400 deferre[r] ... See full document
10
Rev. Bras. Hematol. Hemoter. vol.37 número5
... The V617F mutation in the Janus kinase 2 ( JAK2 ) gene produces an altered protein that constitutively activates the Janus kinase/signal transduc- ers and activators of transcription pat[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.37 número5
... Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate. Brenner H, Gondos A[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.37 número5
... 18. Bassit L, Takei K, Hoshino-Shimizu S, Nishiya AS, Sabino EC, Bassit RP, et al. New Prevalence Estimate of TT virus (TTV) infection in low- and high-risk population from São Paulo, Brazil. Rev Inst Med Trop Sao ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.37 número5
... This study aimed to compare the frequency of haptoglobin genotypes and the interleukin-6 and -8 concentrations in sickle cell anemia patients and controls to investigate the associ- atio[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.37 número5
... Alloimmunized and control groups were compared in terms of the median age of transfused units, the percentage of older RBC units (>14 days of storage)/fresher RBC units ( ≤ 14 days of[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.37 número5
... To predict the clinical significance of anti-Wr a , the mono- cyte monolayer assay (MMA) was performed as previously described 9 in two samples with anti-Wr a classified as IgG1 and one [r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.37 número5
... The samples typed as D negative and C or E positive, as described above, were tested for weak D (IAT) using three protocols: anti-D blend clones MS-26 and TH-28 (Diamed, Switzerland) in a tube; anti-D blend clones MS-26 ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.37 número5
... Incidence of alpha thalassemia, Factor V Lieden, Prothrombin gene mutation and determination of haplotypes of beta globin gene in children with sickle cell disease diagnosed by neonatal [r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.37 número5
... Previously, 167 first-degree relatives pertaining to sporadic (non-familial) chronic lym- phocytic leukemia families were studied and the presence of seven monoclonal B-cell lymphocytosi[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.37 número5
... donors with absent reactivity in the screening test, and if the results are weakly positive, the donors must be classified as RhD-positive in order to prevent anti-D alloimmunization in [r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.37 número5
... Severe iron deficiency Anemia of chronic disease Sideroblastic anemia Lead poisoning Juvenile myelomonocytic leukemia Acquired Hb H disease Acute myeloid leukemia (some cases, particular[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.37 número5
... Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Iriuchishima H, Saitoh T, Handa H, Isoda A, M[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.37 número6
... Therefore, this study does not support data published for patients without neutropenia; the CD64 index was not able to predict positive blood culture results in this specific popu- latio[r] ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.37 número6
... Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.37 número6
... The exclusion criteria were (1) donors who were previously aware of their serological status for HBV and HCV; (2) donors with positive serologic screening tests for human immuno- deficie[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.37 número6
... Figure 3 – Leukemia-free survival according to minimal residual disease based on real-time quantitative polymerase chain reaction at the end of induction in 44 children with acute lympho[r] ... See full document
8
Rev. Bras. Hematol. Hemoter. vol.37 número6
... 2. Pilcante JE, Rojas P, Ajenjo M, Sarmiento M, Ocqueteau M, Ernst D, et al. Clostridium difficile infection in patients undergoing hematopoietic cell transplantation. Results from the transplantation group at the ... See full document
2
temas relacionados